Supporting these results, Zhao et al. demonstrated that BCL9 expression negatively correlates with dendritic cell infiltration in breast cancer, suggesting a broader role for BCL9 inhibition in shaping a favorable immune microenvironment across multiple cancer types [63]. This evidence concerns the gene BCL9 and breast cancer.